IL-17 receptor A antigen binding proteins
US10208122B2 · kind B2 · utility
2Cited by
33References
5Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Mar 2, 2016 |
| Grant date | Feb 19, 2019 |
| Priority date | — |
| Expiry date | Mar 2, 2036 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2317/92
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Disclosed is an isolated human monoclonal antibody that specifically binds IL-17 Receptor A, or an IL-17 Receptor A binding fragment thereof, and inhibits IL-17A from binding and activating the receptor. The present disclosure also provides compositions and methods for treating diseases mediated by IL-17 Receptor A activation.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.